Related Experiment Video
Updated: Sep 23, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Structural identification of vasodilator binding sites on the SUR2 subunit
Dian Ding1,2,3,4, Jing-Xiang Wu1,4, Xinli Duan5
1State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, 100871, Beijing, China.
Small molecule drugs called KATP openers activate ATP-sensitive potassium channels (KATP) by binding to a common site on SUR2 subunits. This binding stabilizes the channel in an occluded state, leading to vasodilation and potential cardiovascular treatments.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- ATP-sensitive potassium channels (KATP), formed by Kir6 and SUR subunits, link cellular metabolism to electrical signaling.
- KATP openers, a class of drugs, activate SUR2-containing channels, causing hyperpolarization and vasodilation, suggesting therapeutic potential for cardiovascular diseases.
Purpose of the Study:
- To elucidate the binding site and activation mechanism of KATP openers on SUR2 subunits.
- To present high-resolution structural insights into KATP channel activation by specific SUR2 ligands.
Main Methods:
- Cryo-electron microscopy (cryo-EM) was used to determine the structures of SUR2A and SUR2B subunits.
- Structures were obtained in complex with Mg-nucleotides and two distinct KATP openers: P1075 and levcromakalim.
Main Results:
- Identified a common binding site for P1075 and levcromakalim within the transmembrane domain (TMD) of the SUR2 subunit.
- Observed that these KATP openers bind between TMD1 and TMD2, interacting with multiple transmembrane helices (TM10, TM11, TM12, TM14, TM17).
- Demonstrated that KATP openers synergize with Mg-nucleotides to stabilize SUR2 in an NBD-dimerized occluded state, thereby activating the channel.
Conclusions:
- The study reveals the precise structural basis for KATP opener binding and activation of SUR2-containing channels.
- These findings provide a molecular understanding of how KATP openers modulate channel activity, paving the way for rational drug design for cardiovascular conditions.
Related Concept Videos
Ligand Binding and Linkage
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...

